Formulation and Delivery
Lynn Kamen, Ph.D.
Scientific Officer and Executive Director
BioAgilytix
Durham, North Carolina
It is widely known that drug development can be an extremely lengthy and time-consuming process that spans decades of work. Throughout the drug development process bioanalytical assays can be transferred throughout the lifecycle of the drug within multiple lab locations and between platform manufacturers. In this presentation, we will highlight the challenges associated with bioanalytical method transfers as well as highlight case studies and strategies for overcoming challenges encountered during method transfer.